NCT07372365
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
2,774 public trials
698 recruiting studies
Lymphoma, Non-Hodgkin trial results
NCT06492837
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Royal Adelaide Hospital Adelaide, Australia
- Liverpool Hospital Liverpool, Australia
- St. Vincent Hospital Melbourne Melbourne, Australia
- Princess Alexandra Hospital Woolloongabba, Australia
NCT06069830
- Conditions
- Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
- Locations
-
- Ruijin Hospital Shanghai, Shanghai Municipality, China
NCT06846463
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B-cell Lymphoma, +13 more
- Locations
-
- Virginia Commonwealth University Richmond, Virginia, United States
NCT06693830
- Conditions
- Diffuse Large B Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Columbia University New York, United States
Recruiting
Anti CD19 Gene Therapy for B-cell Lymphoma
NCT07211048
- Conditions
- B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Anhui Provincial Hospital Hefei, Anhui, China
Recruiting
Avo In R/R And Previously Untreated MCL
NCT04855695
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- University of Chicago Medical Center Chicago, Illinois, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Recruiting
Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma
NCT07077512
- Conditions
- Follicular Lymphoma ( FL), Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Sun Yat-sen Universitiy Cancer Center Guangzhou, China
- Fifth Affiliated Hospital of Guangzhou Medical University Guangzhou, China
- Guangzhou overseas Chinese hospital Guangzhou, China
NCT07355699
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Beijing Tongren Hospital Beijing, China
- Peking Union Medical College Hospital Beijing, China
- The First Affiliated Hospital of China Medical University Beijing, China
- Conditions
- Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Follicular Lymphoma, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, North Carolina, United States